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For more than 40 years, the oligomeric state of members of the mitochondrial carrier
family (SLC25) has been the subject of debate. Initially, the consensus was that they
were dimeric, based on the application of a large number of different techniques.
However, the structures of the mitochondrial ADP/ATP carrier, a member of the family,
clearly demonstrated that its structural fold is monomeric, lacking a conserved dimerisa-
tion interface. A re-evaluation of previously published data, with the advantage of hind-
sight, concluded that technical errors were at the basis of the earlier dimer claims. Here,
we revisit this topic, as new claims for the existence of dimers of the bovine ADP/ATP
carrier have emerged using native mass spectrometry of mitochondrial membrane vesi-
cles. However, the measured mass does not agree with previously published values, and
a large number of post-translational modifications are proposed to account for the differ-
ence. Contrarily, these modifications are not observed in electron density maps of the
bovine carrier. If they were present, they would interfere with the structure and function of
the carrier, including inhibitor and substrate binding. Furthermore, the reported mass
does not account for three tightly bound cardiolipin molecules, which are consistently
observed in other studies and are important stabilising factors for the transport mechan-
ism. The monomeric carrier has all of the required properties for a functional transporter
and undergoes large conformational changes that are incompatible with a stable dimer-
isation interface. Thus, our view that the native mitochondrial ADP/ATP carrier exists and
functions as a monomer remains unaltered.
Introduction
The determination of the oligomeric state of transport proteins is an important step in resolving their
mechanism. The oligomeric state can be assessed by different sizing techniques, by binding and trans-
port studies or by biophysical and structural methods. However, these studies are often marred with
controversy. Since these experiments deal with membrane proteins, they are technically challenging, as
many complicating factors often lead to incorrect assignments of the oligomeric state.
In this review, we discuss studies related to the oligomeric state of the mitochondrial ADP/ATP
carrier, also called the adenine nucleotide translocator or translocase, which belongs to the mitochon-
drial carrier family (SLC25) [1–4]. Mitochondrial carriers form the largest solute carrier family in
humans and are involved in the transport of amino acids, carboxylic acids, fatty acids, cofactors, inor-
ganic ions and nucleotides across the mitochondrial inner membrane [1–4]. Their transport activities
are central to many cellular processes, such as the oxidation of degradation products of fats and
sugars, the synthesis of iron sulfur clusters and haem, and the degradation, synthesis and interconver-
sion of amino acids, as well as mitochondrial macromolecular synthesis, ion homeostasis, heat produc-
tion, mitochondrial dynamics, signalling, cellular differentiation, development and cell death [1–3,5].
Disease variants of mitochondrial carriers lead to a diverse range of neuromuscular, metabolic and
developmental diseases [3,4].
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The mitochondrial ADP/ATP carrier is the best-studied member of the SLC25 family. It was one of the first
transporters to be characterised in detail, because of its natural abundance [6–8]. Based on a careful analysis of
the binding properties of two specific inhibitors, carboxyatractyloside and bongkrekic acid, an alternating
access mechanism was proposed, also called the single binding centre gated pore mechanism [6]. When the
first amino acid sequences were determined [9–11], it became clear that mitochondrial carriers consist of three
homologous repeats [12] and have six transmembrane α-helices [13]. Back then, it was thought that a six-
helical membrane protein might be too small for transporting large substrates, such as ATP and palmitoyl car-
nitine. A dimer would be more compatible with the 12 α-helical topologies generally observed at the time and
it was suggested that dimerisation might be a key generic property of transporters [14]. The results of a large
number of biophysical and biochemical experiments subsequently seemed to support the notion that mitochon-
drial carriers exist and function as dimers (reviewed in [15]). However, when the first structural information
became available, it became clear that the mitochondrial ADP/ATP carrier is a monomer with a three-fold
pseudo-symmetrical structure and a translocation pathway through the centre, indicating that it could work as
a monomer as well [16]. Subsequent atomic structures have supported a monomeric fold of the mitochondrial
ADP/ATP carrier [1,8,17–19]. One structural study suggested that dimerisation might be mediated via cardioli-
pin interactions, based upon analysis of the protein–protein interactions that form the crystal [20]. However,
these interactions are weak and would provide no specificity of recognition in the presence of 50 structurally
related but functionally different mitochondrial carriers present in the inner membrane. Since crystallization
conditions are designed to favour protein–protein interactions, analysis of crystal packing will potentially reveal
non-physiological oligomers [21]. A careful re-examination of all packing arrangements has shown that there is
no conserved dimerisation interface, indicating that the carriers are structural monomers [17]. The only verified
exception in the SLC25 family is the mitochondrial aspartate/glutamate carrier, which forms a structural dimer
due to its unusual architecture [22]. In addition to a carrier domain, which is similar in structure to the mito-
chondrial ADP/ATP carrier, it has an N-terminal calcium regulatory domain and C-terminal amphipathic
helix. Aspartate/glutamate carriers dimerise via their regulatory domains, as five of the eight EF-hand motifs
have evolved away from their canonical calcium-binding function to form an extensive dimerisation interface.
In contrast, the two carrier domains do not interact and are likely to transport as separate units [22]. The mito-
chondrial ATP-Mg/phosphate carrier also has a calcium regulatory domain, but it has a different architecture
and is a structural monomer [23–25].
So, why did the earlier studies conclude that mitochondrial carriers are dimers? We have extensively
reviewed these issues in 2010 [15], but it is worthwhile highlighting some of the key points, as the same tech-
nical mistakes are still made. First of all, it is extremely important to use a good quality starting material for
studies of the oligomeric state. Mitochondrial carriers are highly dynamic membrane proteins with very few
polar interactions stabilising their structures, which can cause major issues with almost every aspect of this ana-
lysis. There are many potential issues with their expression, targeting, insertion and folding, when they are pro-
duced through heterologous expression. In the Gram-negative bacterium Escherichia coli they end up in
inclusion bodies in a misfolded and aggregated state [26], whereas in the Gram-positive bacterium Lactococcus
lactis they are targeted to the cytoplasmic membrane [27–30], but a fraction might be misfolded [28].
Mitochondrial carriers expressed in the inner mitochondrial membrane of yeast or mammalian cells, using the
endogenous synthesis, targeting, insertion and folding pathways, are the best starting point. Yeast is preferred
because cultures can be scaled up easily, a requirement for studying organellar membrane proteins that are
comparatively in low abundance [31–33].
Oligomeric state of mitochondrial carriers in detergent
Purified carrier in detergent is a good starting point, as its oligomeric state can be determined away from con-
taminants. Detergents are required to solubilise the carrier from the lipidic membrane and to take it through
several purification steps to obtain a pure sample. The choice of detergent is crucial, as harsh detergents can
intercalate and unfold the protein, leading to structural instability and aggregation, an artificial state. It is also
possible that detergents can separate oligomers into protomers, misrepresenting its true nature. However, if a
suitably mild detergent is chosen, its atomic structure and oligomeric state are preserved, as observed for many
other transporters, such as the dimeric Na+/H+ antiporter [34], Na+/betaine symporter BetP [35], the band
3 protein [36] and the trimeric sodium/aspartate symporter GltPh [37]. Analysis of the oligomerization inter-
faces of membrane proteins shows features shared with those of soluble proteins: the interfaces tend to be large
and tightly packed, involving a multitude of residues [38].
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When any sizing method is used, it is extremely important to account for the contribution of the detergent/
lipid micelle associated with the membrane protein. As mitochondrial carriers are relatively small, the contribu-
tion of the micelle to the total mass can be relatively large. In size exclusion chromatography, the total mass of
the yeast ADP/ATP carrier can be as much as 115 kDa in dodecylmaltoside or 134 kDa in tridecylmaltoside.
However, when the detergent/protein weight ratios are determined, giving 2.4 and 3.0, respectively, the carriers
are clearly monomeric (33.8 and 33.5 kDa) [39,40].
In blue native gel electrophoresis, the molecular mass of mitochondrial carriers is systematically overestimated,
because they run as a protein/detergent/lipid/Coomassie complex rather than a protein/Coomassie complex, as
often assumed [41]. The size changes with different detergent and lipid content of the associated micelle, showing
that they are key factors. By complete coincidence, the apparent mass of the protein in dodecylmaltoside comes
out to be ∼66 kDa, which is roughly twice the theoretical molecular mass, but when contributions of detergent,
lipid and Coomassie are taken into account, it is a monomer [41]. In the case of the mitochondrial pyruvate
carrier (SLC54) in digitonin, the molecular mass was 150 kDa in blue native gel electrophoresis [42], but in
reality, it is 31 kDa [43]. Thus, this method is not a reliable sizing technique for small membrane proteins [41].
Another important technical issue has been that protein assays can be adversely affected by the presence of
detergents and lipids. When a protein is purified in Triton X-100, the modified Lowry assay overestimates the
protein content considerably [44], which has affected the outcome of binding studies with inhibitors, resulting in
inhibitor/carrier stoichiometries of 1 : 2 [45–47]. It is better to use the bicinchoninic acid assay, or better still,
amino acid analysis, which provides an accurate measure of protein concentration, irrespective of the detergent
and lipid content of the sample. We now know that the inhibitor/carrier stoichiometries are 1 : 1 from calorimetry
measurements [48] and structural analysis [17–19]. The quantification of protein has also affected the inter-
pretation of analytical ultracentrifugation data due to the overestimation of the protein contribution [49,50], but
subsequent studies have confirmed that the carriers are monomeric using this technique [39,51].
Small-angle neutron scattering (SANS) offers the potential for determining the oligomeric state of membrane
proteins in detergent solution, since contrast matching by deuterium exchange can allow the contributions
from lipid and detergent to be removed from the scattering data [52]. However, bovine AAC1 in LAPAO was
estimated to be 53, 56 or 61 kDa [53] and more recently 44 kDa [51], reflecting the difficulties with completely
masking the contribution of lipid/detergent micelles by deuterium exchange when in large excess, leading to an
overestimation of the protein mass.
The combination of size exclusion chromatography with multi-angle laser light scattering (SEC-MALLS) is a
reliable method for determining the mass of membrane protein in a micelle, which can accurately account for
the contributions from detergent and lipid [54]. It has been successfully applied to several mitochondrial trans-
porters [22,43], giving the correct mass, but it is essential that they are separated fully from contaminants and
free detergent micelles [54].
To analyse whether membrane proteins form a complex in detergents, one can also apply a differential tagging
strategy, where tagged and untagged versions of the protein are co-expressed in the membrane and purified by
affinity chromatography [55]. If they were to form a complex, the untagged proteins should co-purify with the
tagged protein upon elution. For the yeast ADP/ATP carrier, all untagged carriers were found in the flow
through, whereas all tagged carriers were found in the elution fraction, showing no state-dependent association
even in the mildest detergents [55]. In our opinion there has never been a valid observation of a dimer of the
mitochondrial ADP/ATP carrier in detergent, when all technical issues are taken into account.
The mitochondrial ADP/ATP carrier functions as a
monomer
A key question that needed to be resolved is whether the mitochondrial ADP/ATP carrier requires dimerisation
for function. One observation that has been held in favour is the autosomal dominant inheritance of progres-
sive external ophthalmoplegia, which is caused by missense mutations in the gene coding for the human ADP/
ATP carrier 1, also called SLC25A4 or ANT1 [56]. However, dominant inheritance per se does not provide
proof for dimer formation, as there are many other genetic mechanisms leading to dominant inheritance, such
as (i) increased gene dosage; (ii) ectopic or temporally altered mRNA expression; (iii) increased or constitutive
protein activity; (iv) altered structural proteins; (v) toxic protein alterations; (vi) new protein function; and
(vii) reduced gene dosage, expression or protein activity, also called haploinsufficiency [57]. It has been esti-
mated that the mitochondrial ADP/ATP carriers in the human body need to transport the equivalent of
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∼65 kg of ADP and ATP across the inner mitochondrial membrane every day to fuel our cellular processes
[58,59]. Given this enormous flux, it is likely that any failure of a fraction of the carrier population would lead
to issues with mitochondrial function and energy provision, and eventually to disease, pointing to haploinsuffi-
ciency as a plausible mechanism. However, genetics alone is not sufficient to resolve these issues conclusively,
as it needs to be investigated by studying negative dominance on protein function directly. In yeast, no negative
dominance was observed in transport, demonstrating that the carriers function independently from each other
in the mitochondrial inner membrane [60]. Furthermore, when the ADP/ATP carrier is tagged with different
lengths of poly-histidine tags, the expression levels decreased with increasing tag length. The growth rates of
the strains expressing these modified carriers on glycerol, a nonfermentable carbon source, decreased with
decreasing expression level, demonstrating haploinsufficiency (unpublished data, Marilyn Harding).
However, the most compelling argument for the carrier being active as a monomer is that it has all of the
functional features required for transport: a single central substrate-binding site and two gates with salt bridge
networks that provide access to one or the other side of the membrane in an alternating way [1,8,17,18,61–64].
The mitochondrial ADP/ATP carrier is a monomer in the
membrane
The one issue that has not been resolved is the oligomeric state of the mitochondrial ADP/ATP carrier in the
inner membrane. There are plenty of cases where membrane proteins or protein complexes function as mono-
mers, but form dimers or oligomers in the membrane, such as the mitochondrial ATP synthase (dimer) [65],
the glutamate transporter (trimer) [66] and aquaporin (tetramer) [67]. The mitochondrial inner membrane is
one of the most densely packed of all and the mitochondrial ADP/ATP carrier is the most abundant protein
therein. Even if the carrier functions as a monomer, it is still possible that it is present in some close-packing
arrangement. There are very few studies that have addressed this particular possibility.
In one study, the bovine ADP/ATP carrier was reconstituted into liposomes and its diameter was determined
by freeze-fracture electron microscopy, giving an average of ∼75 Å [68]. No correction for the thickness of the
stain layer was carried out, which can be as much as ∼17 Å [69]. The matrix side of the bovine ADP/ATP
carrier has a diameter of ∼42 Å and is the only part that protrudes significantly from the membrane [64,70].
Thus, the size of the observed particles, corrected for the contribution of the stain layer, is only compatible
with a monomer. The particles are not dimeric, otherwise, they would have had a pronounced elongated
appearance, which is not evident in the micrographs, nor do they form ordered clusters. In another study, high-
density membranes with reconstituted yeast ADP/ATP carrier did not show any systematic dimeric arrange-
ments, when scanned with atomic force microscopy [70]. Thus, these studies show that the carriers do not
form preferred dimeric interactions in membranes after reconstitution, but they do not address what happens
in the mitochondrial membrane itself.
Recently, new claims for a dimeric state of the bovine ADP/ATP carrier have emerged based on native mass
spectrometry of injected mitochondrial membranes [71], although it should be noted that the method has
already attracted criticism for the failure to preserve the quaternary structure and oligomeric state of mitochon-
drial complexes [72]. Native mass spectrometry is an established technique for the analysis of the oligomeric
state and the chemical composition of tightly bound molecules to membrane proteins, purified in detergents
[73–75]. These native mass spectra are complex because of the binding of lipid and detergent molecules in vari-
able amounts, as well as ligands and contaminants. In the new approach, membrane vesicles are injected dir-
ectly, giving the combined mass spectra of hundreds of different membrane proteins and membrane-associated
proteins in variable relative abundance and charge. The interpretation of these spectra is extremely complex,
complicated further by the association of different molecules and by post-translation modifications.
In the study in question, masses were assigned to both monomeric and dimeric states of the mitochondrial
ADP/ATP carrier in isolated membranes from bovine heart, giving 33 195 and 66 387 Da, respectively [71], with
the dimer being the most abundant form. The molecular mass of the bovine ADP/ATP carrier has been deter-
mined independently twice before. The first-ever amino acid sequence for the SLC25 family was determined by
peptide sequencing of proteolytic fragments of the purified native bovine carrier. The study concluded that the
mature protein lacks the N-terminal Met and has an acetylated Ser1 and a trimethylated Lys51 [9,76,77], giving a
total mass of 32 921 Da. Residue numbering consequently differs from the protein encoded by the gene, but is
consistent with the Protein Data Bank entries of the bovine structure (1OKC, 2C3E) [19]. The first two modifica-
tions are common in mitochondrial carriers, e.g. the uncoupling protein [10,48], and the third has been observed
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in other mitochondrial proteins, e.g. the c-ring of mitochondrial ATP synthase [78], for which a specific methyl-
transferase has been identified [79]. The second independent study carried out a total molecular mass determin-
ation of purified bovine carrier using mass spectrometry, and concluded that it was 32 925.3 ± 3.2 Da [80], which
agrees with the mass of the modified protein determined from the first study. Thus, there is a clear discrepancy
between the mass observed in native mass spectrometry [71] and the one determined by protein sequencing [9]
and mass spectrometry [80], which is not accounted for by experimental error. In a subsequent study, this dis-
crepancy was attributed to a large number of post-translational modifications [81]. In addition to the ones men-
tioned above, they observed O-acetylation of another four residues, Thr23, Tyr50, Tyr111 and Tyr190,
N-succinylation of Lys22 and Lys271, and N-trimethylation of Lys9. They note that there might be other modifi-
cations, but only the ones with high confidence are reported. This extensively modified carrier must be the pre-
dominant species in the membrane, as no other was discernable in the native mass spectrometry data. Since
high-resolution structures of the bovine ADP/ATP carrier have been solved, we checked whether there is any evi-
dence for the additional post-translational modifications in the electron density maps [19,20]. In any crystal
structure, regions of a protein can be disordered and hence show weak or no electron density, which cannot be
reliably modelled. To avoid these issues, we have focussed on the structure solved at the highest resolution
(2.2 Å, PDB code: 1OKC), and on residues that lie in well-ordered regions, with low B-factors, where the electron
density map shows clear density for backbone carbonyl oxygens and water molecules. A careful inspection of
these sites shows that there are no additional unexplained electron densities near the side chains of these resi-
dues, and hence no evidence for their post-translational modification (Figure 1). To exclude the remote possibil-
ity that the bulk-solvent model used in crystallographic refinement and map calculation might have flattened the
electron density near the side chains, we have calculated a polder OMIT map for each residue [82]. These maps
confirm that there is no crystallographic support for the proposed post-translational modifications. Thus, the
data from three different techniques are consistent with each other with respect to the mass and level of modifi-
cation [9,76,80], but not with those observed by native mass spectrometry [71,81].
Next, we inspected the sites of the proposed modifications in the context of the structure and mechanism of the
ADP/ATP carrier. In the structure, residues Thr23, Tyr50 and Lys271 are involved in key interactions that stabilise
the domain structures, and their modification would lead to disruption and destabilisation of the carrier (Figure 1).
Tyr50, which is bonded to two other residues, is in a structural environment that could not possibly accommodate
an acetylation modification. Thr23 is inaccessible for modification in the cytoplasmic-state, where the side-chain is
packed between a neighbouring transmembrane α-helix and the lipid bilayer, and in the matrix-state, where it is
buried in the bilayer [18,19]. Therefore, Thr23 and Tyr50 could only become modified when the protein is unfolded.
To justify the assignment of the 33 195 Da mass to the ADP/ATP carrier, control experiments were per-
formed in which two specific inhibitors were added to the membrane prior to analysis by native mass spec-
trometry [81]. The experimental conditions are not described, and a concentration dependency of binding was
not determined, and thus it is impossible to verify whether the observed low-level binding is specific or non-
specific. However, we can confirm that N-succinylation of Lys22 would interfere with the binding of these inhi-
bitors, as the modification would be located in their binding pockets (Figure 2). The amine group of Lys22
binds via an ordered water to the carboxyl group of carboxyatractyloside in the cytoplasmic state of the bovine
carrier [17,19] (Figure 2C). In the matrix state structure of the ADP/ATP carrier of Thermothelomyces thermo-
phila, Lys30, the equivalent residue of Lys22, binds directly to a carboxyl group of bongkrekic acid [18]
(Figure 2D). So, in both cases, the proposed modification would abolish these interactions. The positively
charged Lys22 is also a key residue in the binding of the negatively charged substrates ADP and ATP (Figure 3)
[8,61–64,83–85]. N-succinylation of Lys22 would (i) introduce a large group in the binding pocket of the sub-
strates and inhibitors, (ii) abolish a positive charge providing key ionic interactions with their negatively
charged functional groups and (iii) introduce a negatively charged modification where the negatively charged
compounds are supposed to bind, creating electrostatic repulsion. It is also possible that the negatively charged
succinyl modification could form ionic interactions with either Arg79 or Arg279, removing two of the three
positive charges from the site, which are crucial for the binding of the substrates. Thus, the highly modified
carrier could not be in a folded and functional state, capable of binding inhibitors or substrates.
A large number of independent studies have reported the importance of three tightly bound cardiolipin mole-
cules in the structure and transport mechanism of mitochondrial carriers, including phosphorous NMR [86],
crystallographic analyses [17–19], lipid analysis [39,40,48,87], disease models [88–90], thermostability measure-
ments [91], transport assays [83,92,93] and coarse grain and molecular dynamics simulations [94–96]. The mea-
sured mass of 33 195 Da, assigned to the bovine ADP/ATP carrier by native mass spectrometry, does not account
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Figure 1. Electron density maps do not support the claimed post-translational modifications of the bovine ADP/ATP
carrier.
The 2mFo−DFc electron density maps around (A) Lys 9, (B) Thr23, (C) Tyr50, (D) Tyr111, (E) Tyr190 and (F) Lys271, shown as
a grey mesh and contoured at the root mean square electron density (1σ), using structure factors and atomic co-ordinates from
the Protein Data Bank (PDB code: 1OKC). The carrier is shown in cartoon representation with side chains as sticks, coloured
by domain (domain 1, blue; domain 2, yellow; domain 3, red), whereas the residues that are claimed to be modified are shown
in green. Cardiolipins are shown in dark grey and carboxyatractyloside in teal. Water molecules are shown as red spheres.
Hydrogen bonds are indicated by black dashed lines, with distances indicated (Å). The side-chain of Asn73, which interacts
with Thr23, has been flipped to maximise its hydrogen-bonding potential.
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for the binding of three cardiolipin molecules, otherwise, it would have been 37 271 Da. Moreover, the spectrum
does not show the typical fine-splitting of the native mass peak due to bound cardiolipin or other lipid molecules
having acyl chains of differing length and saturation. To explain the missing cardiolipin molecules, it was incor-
rectly asserted that the cardiolipins observed in the crystal structures were present because cardiolipin was added
during purification and crystallisation trials [81]. Actually, in most cases, the carrier was isolated directly from the
mitochondrial inner membrane in detergent solutions without cardiolipin addition [17,19,20]. Cardiolipin mole-
cules are so tightly bound that extensive washing with detergents does not remove them [39,48]. Cardiolipin
binding occurs at three specific sites in the mitochondrial ADP/ATP carrier, which have special properties
(Figure 4A). The two negatively charged phosphate moieties of cardiolipin are bound between the N-terminus of
the even-numbered helix of one domain and the N-terminus of the matrix helix of the proximal domain. They
Figure 2. Structures of mitochondrial ADP/ATP carriers inhibited by specific inhibitors.
(A) Lateral view of the structure of the bovine ADP/ATP carrier (PDB code: 1OKC) trapped in the cytoplasmic-state by the
inhibitor carboxyatractyloside (CATR), which was refined with the correct stereo-isoform of CATR [107]. (B) Lateral view of the
structure of the ADP/ATP carrier of Thermothelomyces thermophila (PDB code: 6GCI) trapped in the matrix-state by the inhibitor
bongkrekic acid (BKA). The carriers are shown in cartoon representation coloured by domain (blue, domain 1; yellow, domain 2;
red, domain 3) and with the gate elements on the even-numbered transmembrane α-helices in grey. Details of protein-inhibitor
interactions are shown in (C) for CATR and (D) for BKA. The lysine residue that is claimed to be succinylated is indicated by a red
label. The inhibitors are shown in teal for CATR and in orange for BKA, whereas cardiolipin molecules are shown in grey. Polar
interactions between protein and inhibitors are indicated by green dotted lines. IM mitochondrial inner membrane.
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are bonded by hydrogen bonds [19,20] and by electrostatic interactions with the positive helix dipole [17,18,64],
explaining their high-affinity binding (Figure 4B). For these reasons, the loop to helix transitions have highly con-
served [YF]xG and [YWF][RK]G motifs, where the glycine residues function as helix breakers [18,64,97]. The
bound cardiolipin molecules are important for the stability and function of the carrier, as they link two adjacent
domains together when the carrier cycles between the matrix and cytoplasmic state.
Since the carrier is relatively small and embedded in a lipid bilayer, and has short loops, most of the protein
is not accessible for enzyme-mediated post-translational modifications. However, reactive metabolites, such as
acetyl-CoA and succinyl-CoA, can potentially directly react with amino acid side chains [98], which could
occur more readily in the mitochondrial matrix, which has an alkaline pH and relatively high concentrations of
these compounds [99–101]. Non-enzymatic acetylation and succinylation of lysines in mitochondrial proteins
has been reported, but they occur with low stoichiometry [102,103]. The acetylation of threonine and tyrosine
residues has been described, but also appears to be rare [104,105]. If real, the modified residues would be
inaccessible to enzymes and there is no known non-enzymatic mechanism for removal of the modifications, so
this cannot be regulatory.
So, how could the highly modified carrier become the dominant form in these studies, whereas it is not observed
at all in other analyses? Significantly, prior to mass spectrometry, the membranes were sonicated in 0.5 M of
ammonium acetate buffer to remove bound ions and to facilitate extraction of proteins from the membrane [106].
The sonication procedures and the high voltages used for electrospray ionisation will have deposited a lot of energy
into the sample, which may explain the unusually high level of modifications. Consistent with this, the experimental
procedures have also led to the disruption of the mitochondrial ATP synthase and complex III dimers, to the
removal of a large number of subunits from complex I and III, and to the complete removal of lipids, normally
associated with membrane proteins [72]. The disrupted interaction surfaces of the mitochondrial complexes are
many orders of magnitude larger than those of any hypothetical carrier dimer, which would only contain a few
amino acids. The protein, assigned to the ADP/ATP carrier by native mass spectrometry, seems to lack all of the
Figure 3. Succinylation of Lys22 would interfere with substrate binding.
(A) Residues of the proposed substrate-binding site, shown in green, in the cytoplasmic state of the bovine ADP/ATP carrier
(PDB:1OKC) [19]. The three positively charged residues (Lys22, Arg79, Arg279) are predicted to form salt bridge interactions
with the negatively charged phosphate groups of the substrates ADP and ATP. Gly182, Ile183, Tyr186 and Ser227 form the
adenine binding pocket. ADP is shown in stick and surface representation at the van der Waals radii of the atoms, for
comparison. (B) The proposed post-translational succinylation of Lys22 (Suc-Lys22), here represented by the three possible
conformers, would sterically hinder substrate binding and significantly alter the electrostatic potential of the binding site by
removing a positive charge and by introducing a negative charge. Moreover, the succinyl modification could form an ionic
interaction with either Arg79 or Arg279, removing two of the three positive charges from the site, compromising the binding of
the negatively charged ADP3− or ATP4−.
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known properties of the native one in the inner membrane of mitochondria, i.e. molecular mass, level of modifica-
tion and cardiolipin binding. If we assume the assignment is correct, these treatments have led to structural destabil-
isation, hyper-modification and delipidation of the mitochondrial ADP/ATP carrier, which could lead to
non-specific aggregation. Under these conditions, any assessment of the oligomeric state becomes pointless, as the
native state and function of these highly labile proteins have not been preserved by the method of analysis.
Simulations addressing the oligomeric state of the
mitochondrial ADP/ATP carrier
Coarse grain simulations have been used to study the behaviour of an ensemble of mitochondrial ADP/ATP
carriers in simulated membranes [71,95]. For these analyses, the carboxyatractyloside-inhibited state of the
ADP/ATP carrier was used, after the removal of the inhibitor. The inhibitor locks the carrier in an abortive
state, which is not part of the transport cycle [6]. Comparisons to the bongkrekic acid-inhibited state have
shown that there are some structural perturbations induced by inhibitor binding consistent with the state being
Figure 4. Three cardiolipin molecules are tightly bound to the mitochondrial ADP/ATP carrier.
(A) Side and matrix view of bovine adenine nucleotide translocase (2CE3), showing three tightly bound cardiolipin molecules.
Domains 1, 2 and 3 are shown in blue, yellow and red, respectively, and the gate elements in grey. The cardiolipin molecules
are shown in cyan and their acyl chains have only been partially modelled. (B) The negatively charged cardiolipin molecules are
tightly bound by electrostatic interactions with the helix dipoles, which have a formal positive charge (δ+), and by hydrogen
bonds between the phosphate moieties and amide groups (blue spheres) of the even-numbered transmembrane helices, here
H4, and matrix helices, here h56. The cardiolipin binding sites are highly conserved and the consensus sequence for the
even-numbered helices (left) and matrix helices (right) is shown. The dashed line represents the inter-domain interface.
IS, intermembrane space; IM inner membrane; MM mitochondrial matrix; CDL cardiolipin molecule.
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abortive [18]. Thus, the question is whether it was a good starting point for this type of analysis. In reality, the
carriers cycle continuously between a cytoplasmic and matrix conformation, each of them being in a different
state, and this currently cannot be modelled accurately. Nevertheless, in these simulations, the carriers form
dimers, trimers, tetramers and higher-order aggregates. Notably, they form predominantly if cardiolipin was
present in the inner leaflet of the membrane [71]. However, and most importantly, the carriers do not associate
in a consistent way and do not have a conserved dimerisation interface. Associations occur on all sides of the
carriers without specificity, roughly following the three-fold pseudo-symmetrical shape of the carrier. Rather
than forming specific dimers, the carriers are arranged in closely-packed clusters without conserved
interactions.
New insight from structural analysis
In the functional mitochondrion, mitochondrial carriers cycle back and forth between the cytoplasmic and
matrix state, both of which have been characterised structurally for the ADP/ATP carrier (Figure 2A,B) [17–19].
The conformational changes involve six elements, which move concomitantly [8,18]. There are three core ele-
ments, which consist of the odd-numbered helices, the matrix helices and one-third of the even-numbered
helices (primary colours, Figure 2A,B) plus three gate elements, which are the C-terminal ends of the even-
numbered helices in each domain (grey colours, Figure 2A,B) [8,18]. During the transition from the cytoplasmic
to the matrix state, the core elements of each domain rock outwards, opening the matrix side of the carrier,
whereas simultaneously the gate elements rotate inwards, closing the cytoplasmic side of the carrier (Figure 2A,
B). The transition between the matrix and cytoplasmic state involves the movement of the same elements, but in
reverse [8,18]. The conformational changes lead to profound changes in shape that are totally incompatible with
a stable dimerisation interface (Figure 2A,B) [63]. Small movements in the substrate-binding site [61–63] trans-
late to large movements on the periphery of the carrier, some as much as 13 Å [18]. The inner membrane of a
fully functional mitochondrion contains 50 different mitochondrial carriers, each in a different conformational
state in the transport cycle at any one time. The carriers cycle between these states approximately a thousand
times per second. With this in mind, and all the other arguments presented in this review, it is simply not pos-
sible that they form stable structural dimers during transport of their substrates.
Perspectives
• Importance of the field: The mitochondrial ADP/ATP carrier performs one of the most import-
ant transport steps in the human body, transporting the spent fuel ADP into the mitochondrion
and the synthesised fuel ATP out to energise processes in the cell.
• Current thinking: Originally it was thought that they were dimers, but all of the sequence,
structural, biophysical and functional data now show that the mitochondrial ADP/ATP carrier
exists and functions as a monomer.
• Future directions: Many structural aspects of the transport mechanism still need to be
resolved to determine how mitochondrial ADP/ATP carriers achieve high transport rates of
adenine nucleotides in the densely packed inner membrane of mitochondria.
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